IDEXX LABORATORIES INC /DE Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEXX LABORATORIES INC /DE for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,156 | 91,948 | 708 | |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.06 | 834 | 173,523 | 4,389 | 5.2 K to 4.4 K (-15.97 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 212.05 | 472 | 100,089 | 5,223 | 5.7 K to 5.2 K (-8.29 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 211.70 | 1,223 | 258,907 | 5,695 | 6.9 K to 5.7 K (-17.68 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,156 | 91,948 | 6,918 | 5.8 K to 6.9 K (+20.06 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Gift | G | 0.00 | 8,000 | 0 | 1,025,884 | 1 M to 1 M (-0.77 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 45.84 | 3,322 | 152,280 | 0 | |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 211.58 | 736 | 155,723 | 5,732 | 6.5 K to 5.7 K (-11.38 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 4,584.00 | 3,322 | 15,228,048 | 6,468 | 3.1 K to 6.5 K (+105.59 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 62.00 | 1,612 | 99,944 | 0 | |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 62.00 | 1,612 | 99,944 | 1,033,884 | 1 M to 1 M (+0.16 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 178.26 | 1,714 | 305,538 | 6,293 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 141.60 | 2,219 | 314,210 | 5,948 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 1 | 68 | 1,474 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 4,700 | 318,895 | 7,927 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 100 | 7,954 | 1,864 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 2,866 | 227,962 | 2,866 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 209.18 | 1,714 | 358,533 | 5,762 | 7.5 K to 5.8 K (-22.93 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 178.26 | 1,714 | 305,538 | 7,476 | 5.8 K to 7.5 K (+29.75 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.95 | 2,219 | 463,665 | 5,762 | 8 K to 5.8 K (-27.80 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 7,981 | 5.8 K to 8 K (+38.51 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.90 | 1 | 209 | 5,762 | 5.8 K to 5.8 K (-0.02 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 1 | 68 | 5,763 | 5.8 K to 5.8 K (+0.02 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.54 | 4,700 | 980,133 | 5,762 | 10.5 K to 5.8 K (-44.92 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 4,700 | 318,895 | 10,462 | 5.8 K to 10.5 K (+81.57 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.80 | 100 | 20,780 | 5,762 | 5.9 K to 5.8 K (-1.71 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 100 | 7,954 | 5,862 | 5.8 K to 5.9 K (+1.74 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 207.54 | 2,866 | 594,796 | 5,762 | 8.6 K to 5.8 K (-33.22 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 2,866 | 227,962 | 8,648 | 5.8 K to 8.6 K (+49.57 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 169 | 0 | 3,183 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 212 | 0 | 3,352 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 405 | 0 | 3,564 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 345 | 0 | 3,969 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 282 | 0 | 4,314 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 785 | 0 | 4,596 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 206.94 | 7,186 | 1,487,071 | 7,186 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Payment of Exercise | F | 206.94 | 428 | 88,570 | 18,678 | 19.1 K to 18.7 K (-2.24 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 169 | 0 | 19,106 | 18.9 K to 19.1 K (+0.89 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 212 | 0 | 18,937 | 18.7 K to 18.9 K (+1.13 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 405 | 0 | 18,725 | 18.3 K to 18.7 K (+2.21 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 345 | 0 | 18,320 | 18 K to 18.3 K (+1.92 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 282 | 0 | 17,975 | 17.7 K to 18 K (+1.59 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 211 | 0 | 3,478 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,689 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,901 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 4,122 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 906 | 0 | 4,310 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 8,366 | 1,731,260 | 8,366 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Payment of Exercise | F | 206.94 | 233 | 48,217 | 3,832 | 4.1 K to 3.8 K (-5.73 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 211 | 0 | 4,065 | 3.9 K to 4.1 K (+5.47 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 3,854 | 3.6 K to 3.9 K (+5.82 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 3,642 | 3.4 K to 3.6 K (+6.46 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 3,421 | 3.2 K to 3.4 K (+5.82 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 169 | 0 | 3,591 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 212 | 0 | 3,760 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 405 | 0 | 3,972 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 345 | 0 | 4,377 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Payment of Exercise | F | 206.94 | 345 | 71,394 | 5,762 | 6.1 K to 5.8 K (-5.65 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 169 | 0 | 6,107 | 5.9 K to 6.1 K (+2.85 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 212 | 0 | 5,938 | 5.7 K to 5.9 K (+3.70 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 405 | 0 | 5,726 | 5.3 K to 5.7 K (+7.61 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 345 | 0 | 5,321 | 5 K to 5.3 K (+6.93 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 7,819 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 8,324 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 811 | 0 | 8,783 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 629 | 0 | 9,594 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 726 | 0 | 10,223 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 2,175 | 0 | 10,949 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 206.94 | 20,753 | 4,294,626 | 20,753 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 206.94 | 1,612 | 333,587 | 47,496 | 49.1 K to 47.5 K (-3.28 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 49,108 | 48.6 K to 49.1 K (+1.04 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 48,603 | 48.1 K to 48.6 K (+0.95 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 811 | 0 | 48,144 | 47.3 K to 48.1 K (+1.71 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 629 | 0 | 47,333 | 46.7 K to 47.3 K (+1.35 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 726 | 0 | 46,704 | 46 K to 46.7 K (+1.58 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 505 | 0 | 7,516 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 459 | 0 | 8,021 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 737 | 0 | 8,480 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 471 | 0 | 9,217 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 403 | 0 | 9,688 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 0.00 | 2,175 | 0 | 10,091 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Option Exercise | M | 206.94 | 20,753 | 4,294,626 | 20,753 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Payment of Exercise | F | 206.94 | 762 | 157,688 | 23,212 | 24 K to 23.2 K (-3.18 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 505 | 0 | 23,974 | 23.5 K to 24 K (+2.15 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 459 | 0 | 23,469 | 23 K to 23.5 K (+1.99 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 737 | 0 | 23,010 | 22.3 K to 23 K (+3.31 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 471 | 0 | 22,273 | 21.8 K to 22.3 K (+2.16 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Executive Vice Pres ... | Buy | M | 0.00 | 403 | 0 | 21,802 | 21.4 K to 21.8 K (+1.88 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 197 | 0 | 2,956 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,153 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,365 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 3,586 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 242 | 0 | 3,774 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 906 | 0 | 4,016 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 206.94 | 8,366 | 1,731,260 | 8,366 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 208.00 | 971 | 201,968 | 3,146 | 4.1 K to 3.1 K (-23.59 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Payment of Exercise | F | 206.94 | 324 | 67,049 | 4,117 | 4.4 K to 4.1 K (-7.30 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 197 | 0 | 4,441 | 4.2 K to 4.4 K (+4.64 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 4,244 | 4 K to 4.2 K (+5.26 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 4,032 | 3.8 K to 4 K (+5.80 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 3,811 | 3.6 K to 3.8 K (+5.19 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 0.00 | 242 | 0 | 3,623 | 3.4 K to 3.6 K (+7.16 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 0.00 | 1,774 | 0 | 0 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 206.94 | 483 | 99,952 | 483 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 206.94 | 78,170 | 16,176,500 | 78,170 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Payment of Exercise | F | 206.94 | 824 | 170,519 | 1,032,272 | 1 M to 1 M (-0.08 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 0.00 | 1,774 | 0 | 1,033,096 | 1 M to 1 M (+0.17 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 47.53 | 5,906 | 280,712 | 0 | |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 208.96 | 5,906 | 1,234,091 | 3,416 | 9.3 K to 3.4 K (-63.36 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,906 | 0 | 9,322 | 3.4 K to 9.3 K (+172.89 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,906 | 0 | 584 | 6.5 K to 584 (-91.00 %) |
| Feb 19 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 47.53 | 5,906 | 280,712 | 6,490 | 584 to 6.5 K (+1,011.30 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 209.08 | 997 | 208,454 | 17,693 | 18.7 K to 17.7 K (-5.33 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Buy | P | 208.68 | 2,405 | 501,875 | 7,403 | 5 K to 7.4 K (+48.12 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,905 | 695,208 | 0 | |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,905 | 695,208 | 15,905 | |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 43.71 | 15,904 | 695,164 | 31,810 | |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 207.17 | 2,998 | 621,100 | 1,031,322 | 1 M to 1 M (-0.29 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 206.54 | 8,800 | 1,817,578 | 1,034,320 | 1 M to 1 M (-0.84 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 205.53 | 4,107 | 844,110 | 1,043,120 | 1 M to 1 M (-0.39 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,905 | 695,208 | 1,047,227 | 1 M to 1 M (+1.54 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 208.53 | 7,428 | 1,548,936 | 1,031,322 | 1 M to 1 M (-0.72 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 207.77 | 8,477 | 1,761,298 | 1,038,750 | 1 M to 1 M (-0.81 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,905 | 695,208 | 1,047,277 | 1 M to 1 M (+1.54 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 206.14 | 100 | 20,614 | 1,031,322 | 1 M to 1 M (-0.01 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 205.81 | 6,041 | 1,243,270 | 1,031,422 | 1 M to 1 M (-0.58 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 204.75 | 8,045 | 1,647,225 | 1,037,463 | 1 M to 1 M (-0.77 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 203.75 | 1,718 | 350,050 | 1,045,508 | 1 M to 1 M (-0.16 %) |
| Feb 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 43.71 | 15,904 | 695,164 | 1,047,226 | 1 M to 1 M (+1.54 %) |
| Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 207.68 | 90 | 18,691 | 9,027 | 8.9 K to 9 K (+1.01 %) |
| Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Grant | A | 207.68 | 120 | 24,922 | 4,998 | 4.9 K to 5 K (+2.46 %) |
| Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 207.68 | 29 | 6,023 | 2,741 | 2.7 K to 2.7 K (+1.07 %) |
| Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 207.68 | 90 | 18,691 | 568 | 478 to 568 (+18.83 %) |